Midlife Health Myths: What's True, What's Not? | LIVE with JJ Virgin

JJ Virgin
JJ VirginJun 10, 2026

Why It Matters

Her guidance reframes common midlife health advice into actionable clinical markers and lifestyle fixes—prioritizing sufficient protein, resistance exercise, and targeted testing can prevent misdiagnosis and unintended harms from popular treatments like GLP‑1s. These recommendations have direct implications for managing menopause-related muscle loss, glucose control, autoimmune triggers, and cardiovascular risk.

Summary

Health coach JJ Virgin used a live Q&A to debunk common midlife wellness myths and give practical guidance for women over 40, covering protein needs, GLP‑1 drugs, autoimmune diets, blood sugar and cholesterol management. She recommends aiming for roughly 30 g of animal protein (or ~40 g plant) per meal to hit leucine targets and protect muscle, and warns that muscle loss attributed to GLP‑1s is usually due to low protein and lack of resistance training. On GLP‑1s she flagged slowed gastric emptying and increased risk of SIBO as a chief long‑term concern, while endorsing benefits like reduced polypharmacy and improved insulin sensitivity. For metabolic health she urged testing fasting insulin, using resistance training, optimizing sleep and vitamin D3/K2, employing CGMs for glucose control, and evaluating LDL particle size rather than LDL alone.

Original Description

Confused by wellness advice after 40? In this LIVE Q&A, JJ Virgin breaks down the biggest midlife health myths around metabolism, menopause, hormones, fasting, protein, supplements, gut health, muscle building, dairy, keto, intermittent fasting, sugar cravings, sleep, and healthy aging.
We’re answering your biggest questions: Does metabolism really slow with age? Is dairy inflammatory? Can women over 50 still build muscle? Do you need hormone replacement? How much protein do women over 40 actually need? And what supplements are worth taking?
👇 NEXT LIVE: July 14th!
Comment below with the topic you want us to cover next.

Comments

Want to join the conversation?

Loading comments...